Lyell Immunopharma Cash Flow Statement (2020-2025) | LYEL

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -100.69M-35.75M-38.90M-55.02M-62.49M-48.89M-47.22M-68.18M-36.31M-64.19M-11.33M-58.06M-60.64M-52.43M-52.42M-48.76M-45.16M-44.54M-196.23M-53.51M-43.86M-33.99M
Share-based Compensation 7.27M9.75M12.97M12.73M15.25M13.04M21.18M22.03M22.41M19.12M18.36M13.88M14.22M10.52M8.46M9.15M8.28M7.62M8.08M6.02M5.00M5.23M
Gains from Sales and Divestitures 2.99M3.97M
Gains from Investment Securities 7.00M0.04M42.18M43.56M36.25M-0.03M5.00M10.00M2.92M13.00M
Asset Writedowns and Impairment 36.45M5.00M-5.00M51.30M1.44M
Non-cash Items 23.16M24.40M
Cash from Operations -21.63M-26.73M-33.60M-33.95M-25.49M-33.21M-47.85M-44.33M-37.10M-40.27M-46.21M-39.16M-37.69M-40.63M-42.02M-38.09M-35.04M-47.24M-54.74M-34.46M-28.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.18M-0.47M-0.48M-0.40M-0.55M-0.47M-0.47M-0.23M0.43M1.21M1.85M2.08M2.29M3.38M4.37M3.76M3.59M2.96M1.73M1.17M1.01M
Depreciation & Amortization (CF) 1.10M1.45M1.96M3.01M4.09M4.57M4.19M4.17M4.62M5.04M5.03M5.06M5.10M5.06M5.02M4.90M4.68M5.03M3.44M3.13M2.57M
Change in Working Capital
Change in Account Payables -0.29M0.34M0.63M0.35M-0.99M0.10M2.94M-1.77M0.02M-0.53M2.07M0.38M-1.41M0.42M-0.11M-0.52M-0.57M-2.04M-1.65M-0.23M-0.78M
Change in Accured Expenses 0.85M1.91M-4.70M3.08M1.94M4.22M-6.39M-0.77M1.32M5.37M-5.86M2.27M4.61M-1.74M-3.61M0.52M3.09M-1.25M-9.79M-3.33M0.57M
Investing Activities
Capital Expenditures 12.64M24.88M19.19M24.45M11.60M10.27M9.73M7.17M2.79M4.58M1.53M0.93M0.20M0.03M0.22M0.14M0.06M0.04M0.25M0.17M0.06M
Change in Acquisitions & Divestments 173.10M205.69M204.16M200.87M142.04M70.33M79.81M121.85M106.50M110.90M142.25M187.10M178.15M156.12M130.03M161.80M133.41M123.70M154.12M93.52M74.14M
Cash from Investing Activities -89.94M32.39M136.68M-39.47M-144.91M-73.86M-26.12M25.02M-57.09M46.65M32.15M152.91M99.67M-100.69M21.99M45.01M1.92M53.51M69.47M12.65M3.35M
Financing Activities
Change in Capital Stock
Shares Issued 0.04M0.34M0.88M391.98M-1.06M2.56M1.57M5.13M0.33M1.16M0.73M0.10M0.71M0.44M0.18M49.82M
Misc.
Cash from Financing Activities 0.04M0.34M0.88M393.49M-0.53M7.40M2.56M2.46M4.76M0.86M-0.07M1.20M-0.14M0.76M0.03M0.86M0.44M0.00M0.18M50.00M
Change in Cash -111.54M5.99M103.96M320.07M-170.94M-99.68M-71.42M-16.86M-89.43M7.24M-14.13M114.95M61.84M-140.57M-20.00M7.78M-33.12M6.70M14.73M-21.63M24.77M
Free Cash Flow -34.27M-51.61M-52.79M-58.39M-37.09M-43.48M-57.59M-51.50M-39.89M-44.85M-47.74M-40.09M-37.88M-40.66M-42.24M-38.23M-35.10M-47.29M-54.98M-34.63M-28.64M
Net Cash Flow -111.54M5.99M103.96M320.07M-170.94M-99.68M-71.42M-16.86M-89.43M7.24M-14.13M114.95M61.84M-140.57M-20.00M7.78M-33.12M6.70M14.73M-21.63M24.77M